Glycomet GP (500+2) mg is a pharmaceutical product that belongs to the category of oral medications used in the management of diabetes. This medication combines two active ingredients, namely Metformin and Glimepiride, to help control blood sugar levels in individuals with type 2 diabetes.
Ingredients
Each tablet of Glycomet GP (500+2) mg contains two active ingredients:
Metformin: Metformin is an oral antidiabetic medication that belongs to the biguanide class. It primarily works by reducing the production of glucose in the liver and enhancing the sensitivity of body tissues to insulin, thus improving the utilization of glucose by cells.
Glimepiride: Glimepiride is a sulfonylurea medication that stimulates the pancreas to release more insulin. This helps lower blood sugar levels by increasing insulin availability.
Product
Glycomet GP (500+2) mg is an oral medication specifically designed for individuals with type 2 diabetes. It is used to regulate blood sugar levels and improve glycemic control. The combination of Metformin and Glimepiride allows for a more comprehensive approach to diabetes management by addressing both insulin sensitivity and insulin production.
Usage
Patients should use Glycomet GP (500+2) mg as directed by their healthcare provider. The typical usage involves taking the tablet by mouth with a meal or as prescribed by the doctor. Dosage and frequency of administration are determined by the healthcare provider based on the patient’s individual diabetes management needs. It is important to follow the prescribed regimen and dietary recommendations.
Manufacturer
Glycomet GP (500+2) mg is manufactured by USV Private Limited, a reputable pharmaceutical company known for producing high-quality medications. USV is committed to ensuring that its pharmaceutical products meet stringent quality standards and adhere to safety regulations.
In summary, Glycomet GP (500+2) mg is an oral medication combining Metformin and Glimepiride, used for the management of type 2 diabetes. It assists in controlling blood sugar levels through its dual-action mechanism. Patients should adhere to their healthcare provider’s guidance for the safe and effective use of Glycomet GP (500+2) mg in managing their diabetes.
Reviews
There are no reviews yet.